Tag: Covera

covered

24-month AVeNEW study results: Covered stent angioplasty “statistically superior” to angioplasty...

Against the backdrop of increasing end-stage renal disease (ESRD) prevalence in the USA, Bart Dolmatch (Portola Valley, USA) presented the 24-month results of the...
covera

Vascular access: Covera stent superior to plain balloon angioplasty in stenotic...

A covered stent provides significantly better target lesion primary patency than percutaneous transluminal angioplasty (PTA) of stenotic lesions in the venous outflow of upper...
Bard Covera stent

e-PTFE covered stent demonstrates “significantly better” target lesion primary patency compared...

The results of AVeNEW, the first level one clinical study dedicated solely to the use of a covered stent designed to treat stenosis in...
covered

Covered stent provides greater patency than angioplasty alone in AV fistulae

The Covera vascular covered stent (BD) has a superior six-month primary patency rate than standard balloon angioplasty, with an equivalent safety at 30 days,...

First data from AVeVA suggest Covera stent “safe and effective” at...

Early data from the prospective multicentre AVeVA study that employed a covered stent (Covera; Bard, now BD) to treat stenoses at the venous anastomosis...